Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms

Clinical Science

Volumn 123, Issue 9, 2012, Pages 531-543

  Lu, Hong ^a   Rateri, Debra L ^a   Bruemmer, Dennis ^a,b   Cassis, Lisa A ^b   Daugherty, Alan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Abdominal aortic aneurysm; Angiotensin; Angiotensin converting enzyme; Renin angiotensin system; Thoracic aortic aneurysm

Indexed keywords

ANGIOTENSIN II; ARACHIDONIC ACID; PROTEINASE; RENIN; SCLEROPROTEIN;

ABDOMINAL AORTA ANEURYSM; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THORACIC AORTA ANEURYSM; ANIMAL; DISEASE MODEL; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; DISEASE MODELS, ANIMAL; HUMANS; MICE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84866242634     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120097     Document Type: Review

References (130)

1. Lederle, F. A., Johnson, G. R., Wilson, S. E., Chute, E. P., Littooy, F. N., Bandyk, D., Krupski, W. C., Barone, G. W., Acher, C. W. and Ballard, D. J. (1997) Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann. Intern. Med. 126, 441-449.
2. Lederle, F. A., Johnson, G. R., Wilson, S. E., Gordon, I. L., Chute, E. P., Littooy, F. N., Krupski, W. C., Bandyk, D., Barone, G. W., Graham, L. M. et al. (1997) Relationship of age, gender, race, and body size to infrarenal aortic diameter. J. Vasc. Surg. 26, 595-601.
3. Milewicz, D. M. and Regalado, E. (2012) Thoracic aortic aneurysms and aortic dissections. 2003 Feb 13 (Updated 2012 Jan 12). GeneReviews (Pagon, R. A., Bird, T. D., Dolan, C. R., Stephens, K. and Adam, M. P., eds.), University of Seattle, Seattle.
4. Lu, H., Rateri, D. L., Cassis, L. A. and Daugherty, A. (2008) The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr. Hypertens. Rep. 10, 99-106.
5. Daugherty, A. and Cassis, L. A. (2004) Mouse models of abdominal aortic aneurysms. Arterioscler., Thromb., Vasc. Biol. 24, 429-434.
6. Longo, G. M., Xiong, W., Greiner, T. C., Zhao, Y., Fiotti, N. and Baxter, B. T. (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110, 625-632.
7. Pyo, R., Lee, J. K., Shipley, J. M., Curci, J. A., Mao, D., Ziporin, S. J., Ennis, T. L., Shapiro, S. D., Senior, R. M. and Thompson, R. W. (2000) Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105, 1641-1649.
8. -/- mice. Ann. N.Y. Acad. Sci. 892, 108-118.
9. Daugherty, A., Manning, M. W. and Cassis, L. A. (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605-1612.
10. Lindsay, M. E. and Dietz, H. C. (2011) Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 473, 308-316.
11. Pereira, L., Lee, S. Y., Gayraud, B., Andrikopoulos, K., Shapiro, S. D., Bunton, T., Biery, N. J., Dietz, H. C., Sakai, L. Y. and Ramirez, F. (1999) Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc. Natl. Acad. Sci. U.S.A. 96, 3819-3823.
12. 1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117-121.
13. Ikonomidis, J. S., Gibson, W. C., Gardner, J., Sweterlitsch, S., Thompson, R. P., Mukherjee, R. and Spinale, F. G. (2003) A murine model of thoracic aortic aneurysms. J. Surg. Res. 115, 157-163.
14. -/- mice. Clin. Sci. 118, 681-689.
15. Thompson, R. W., Curci, J. A., Ennis, T. L., Mao, D., Pagano, M. B. and Pham, C. T. (2006) Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann. N.Y. Acad. Sci. 1085, 59-73.
16. Liao, S., Miralles, M., Kelley, B. J., Curci, J. A., Borhani, M. and Thompson, R. W. (2001) Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg. 33, 1057-1064.
17. Kaschina, E., Schrader, F., Sommerfeld, M., Kemnitz, U. R., Grzesiak, A., Krikov, M. and Unger, T. (2008) Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. J. Hypertens. 26, 2361-2373.
18. Fujiwara, Y., Shiraya, S., Miyake, T., Yamakawa, S., Aoki, M., Makino, H., Nishimura, M. and Morishita, R. (2008) Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int. J. Mol. Med. 22, 703-708.
19. Deng, G. G., Martin-McNulty, B., Sukovich, D. A., Freay, A., Halks-Miller, M., Thinnes, T., Loskutoff, D. J., Carmeliet, P., Dole, W. P. and Wang, Y. X. (2003) Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ. Res. 92, 510-517.
20. Uchida, H. A., Poduri, A., Subramanian, V., Cassis, L. A. and Daugherty, A. (2011) Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. Arterioscler. Thromb.,Vasc. Biol. 31, 2845-2852.
21. Police, S. B., Thatcher, S. E., Charnigo, R., Daugherty, A. and Cassis, L. A. (2009) Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb., Vasc. Biol. 29, 1458-1464.
22. Police, S. B., Putnam, K., Thatcher, S., Batifoulier-Yiannikouris, F., Daugherty, A. and Cassis, L. A. (2010) Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms. Am. J. Physiol. Heart Circ. Physiol. 298, H1932-H1938.
23. Manning, M. W., Cassis, L. A., Huang, J., Szilvassy, S. J. and Daugherty, A. (2002) Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc. Med. 7, 45-54.
24. Henriques, T. A., Huang, J., D'Souza, S. S., Daugherty, A. and Cassis, L. A. (2004) Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 145, 3866-3872.
25. 1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 28, 1251-1256.
26. Zhang, X., Thatcher, S. E., Rateri, D. L., Bruemmer, D., Charnigo, R., Daugherty, A. and Cassis, L. A. (2012) Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ. Res., doi: 10.1161/CIRCRESAHA.111.253880.
27. Lederle, F. A., Johnson, G. R., Wilson, S. E., Chute, E. P., Hye, R. J., Makaroun, M. S., Barone, G. W., Bandyk, D., Moneta, G. L. and Makhoul, R. G. (2000) The aneurysm detection and management study screening program: validation cohort and final results. Arch. Intern. Med. 160, 1425-1430.
28. Cassis, L. A., Gupte, M., Thayer, S., Zhang, X., Charnigo, R., Howatt, D. A., Rateri, D. L. and Daugherty, A. (2009) Angiotensin II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am. J. Physiol. Heart Circ. Physiol. 296, H1660-H1665.
29. Daugherty, A., Cassis, L. A. and Lu, H. (2011) Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J. Zhejiang Univ. Sci. B. 12, 624-628.
30. Saraff, K., Babamusta, F., Cassis, L. A. and Daugherty, A. (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 23, 1621-1626.
31. Barisione, C., Charnigo, R., Howatt, D. A., Moorleghen, J. J., Rateri, D. L. and Daugherty, A. (2006) Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J. Vasc. Surg. 44, 372-376.
32. Goergen, C. J., Azuma, J., Barr, K. N., Magdefessel, L., Kallop, D. Y., Gogineni, A., Grewall, A., Weimer, R. M., Connolly, A. J., Dalman, R. L. et al. (2011) Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler., Thromb., Vasc. Biol. 31, 270-279.
33. -/- mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysms. Am. J. Pathol. 179, 1542-1548.
34. Powell, J. T. and Brady, A. R. (2004) Detection, management and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler., Thromb., Vasc. Biol. 24, 241-245.
35. Wolinsky, H. and Glagov, S. (1969) Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ. Res. 25, 677-686.
36. Tangirala, R. K., Rubin, E. M. and Palinski, W. (1995) Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36, 2320-2328.
37. Kuhlencordt, P. J., Gyurko, R., Han, F., Scherrer Crosbie, M., Aretz, T. H., Hajjar, R., Picard, M. H. and Huang, P. L. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454.
38. Boucher, P., Gotthardt, M., Li, W. P., Anderson, R.G.W. and Herz, J. (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300, 329-332.
39. Goergen, C. J., Barr, K. N., Huynh, D. T., Eastham-Anderson, J. R., Choi, G., Hedehus, M., Dalman, R. L., Connolly, A. J., Taylor, C. A., Tsao, P. S. and Greve, J. M. (2010) In vivo quantification of murine aortic cyclic strain, motion, and curvature: implications for abdominal aortic aneurysm growth. J. Magn. Reson. Imaging. 32, 847-858.
40. Moore, Jr, J. E., Maier, S. E., Ku, D. N. and Boesiger, P. (1994) Hemodynamics in the abdominal aorta: a comparison of in vitro and in vivo measurements. J. Appl. Physiol. 76, 1520-1527.
41. Nistala, H., Lee-Arteaga, S., Carta, L., Cook, J. R., Smaldone, S., Siciliano, G., Rifkin, A. N., Dietz, H. C., Rifkin, D. B. and Ramirez, F. (2010) Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum. Mol. Genet. 19, 4790-4798.
42. Tieu, B. C., Lee, C., Sun, H., Lejeune, W., Recinos, III, A., Ju, X., Spratt, H., Guo, D. C., Milewicz, D., Tilton, R. G. and Brasier, A. R. (2009) An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Invest. 119, 3637-3651.
43. -/- mice. Circ. Res. 108, 574-581.
44. Golledge, J., Muller, J., Daugherty, A. and Norman, P. (2006) Abdominal aortic aneurysm. Pathogenesis and implications for management. Arterioscler., Thromb., Vasc. Biol. 26, 2605-2613.
45. Weintraub, N. L. (2009) Understanding abdominal aortic aneurysm. N. Engl. J. Med. 361, 1114-1116.
46. Rush, C., Nyara, M., Moxon, J. V., Trollope, A., Cullen, B. and Golledge, J. (2009) Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm. BMC Genomics 10, 298.
47. Spin, J. M., Hsu, M., Azuma, J., Tedesco, M. M., Dyer, J. S., Maegdefessel, L., Dalman, R. L. and Tsao, P. S. (2011) Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol. Genomics 43, 993-1003.
48. 2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134, 865-870.
49. 1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler., Thromb., Vasc. Biol. 27, 380-386.
50. Babamusta, F., Rateri, D. L., Moorleghen, J. J., Howatt, D. A., Li, X. A. and Daugherty, A. (2005) Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice. Atherosclerosis 186, 282-290.
51. Ishibashi, M., Egashira, K., Zhao, Q., Hiasa, K., Ohtani, K., Ihara, Y., Charo, I. F., Kura, S., Tsuzuki, T., Takeshita, A. and Sunagawa, K. (2004) Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler., Thromb., Vasc. Biol. 24, 174-178.
52. Owens, III, A. P., Rateri, D. L., Howatt, D. A., Moore, K. J., Tobias, P. S., Curtiss, L. K., Lu, H., Cassis, L. A. and Daugherty, A. (2011) MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. Arterioscler., Thromb., Vasc. Biol. 31, 2813-2819.
53. Findeisen, H. M., Gizard, F., Zhao, Y., Cohn, D., Heywood, E. B., Jones, K. L., Lovett, D. H., Howatt, D. A., Daugherty, A. and Bruemmer, D. (2011) Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler., Thromb., Vasc. Biol. 31, 253-260.
54. Uchida, H. A., Kristo, F., Rateri, D. L., Lu, H., Charnigo, R., Cassis, L. A. and Daugherty, A. (2010) Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice. Atherosclerosis 211, 399-403.
55. King, V. L., Lin, A. Y., Kristo, F., Anderson, T. J., Ahluwalia, N., Hardy, G. J., Owens, III, A. P., Howatt, D. A., Shen, D., Tager, A. M. et al. (2009) Interferon-γ and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 119, 426-435.
56. Eagleton, M. J., Xu, J., Liao, M., Parine, B., Chisolm, G. M. and Graham, L. M. (2010) Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation. J. Vasc. Surg. 51, 951-961.
57. Wang, Y., Ait-Oufella, H., Herbin, O., Bonnin, P., Ramkhelawon, B., Taleb, S., Huang, J., Offenstadt, G., Combadiere, C., Renia, L. et al. (2010) TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Invest. 120, 422-432.
58. Zhang, L. N., Velichko, S., Vincelette, J., Fitch, R. M., Vergona, R., Sullivan, M. E., Croze, E. and Wang, Y. X. (2007) Interferon-β attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis 197, 204-211.
59. Xanthoulea, S., Thelen, M., Pottgens, C., Gijbels, M. J., Lutgens, E. and de Winther, M. P. (2009) Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS ONE 4, e6113.
60. Wang, Y. X., Martin-McNulty, B., Freay, A. D., Sukovich, D. A., Halks-Miller, M., Li, W. W., Vergona, R., Sullivan, M. E., Morser, J., Dole, W. P. and Deng, G. G. (2001) Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am. J. Pathol. 159, 1455-1464.
61. Gavrila, D., Li, W. G., McCormick, M. L., Thomas, M., Daugherty, A., Cassis, L. A., Miller, Jr, F. J., Oberley, L. W., Dellsperger, K. C. and Weintraub, N. L. (2005) Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 25, 1671-1677.
62. Eagleton, M. J., Ballard, N., Lynch, E., Srivastava, S. D., Upchurch, Jr, G. R. and Stanley, J. C. (2006) Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during angiotensin II induced aneurysm formation. J. Surg. Res. 135, 345-351.
63. Manning, M. W., Cassis, L. A. and Daugherty, A. (2003) Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler., Thromb., Vasc. Biol. 23, 483-488.
64. Turner, G. H., Olzinski, A. R., Bernard, R. E., Aravindhan, K., Karr, H. W., Mirabile, R. C., Willette, R. N., Gough, P. J. and Jucker, B. M. (2008) In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI. Circ. Cardiovasc. Imaging 1, 220-226.
65. Qian, H. S., Gu, J. M., Liu, P., Kauser, K., Halks-Miller, M., Vergona, R., Sullivan, M. E., Dole, W. P. and Deng, G. G. (2008) Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice. Gene Ther. 15, 224-232.
66. Yamanouchi, D., Morgan, S., Kato, K., Lengfeld, J., Zhang, F. and Liu, B. (2010) Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 30, 702-707.
67. Subramanian, V., Uchida, H. A., Ijaz, T., Moorleghen, J. J., Howatt, D. A. and Balakrishnan, A. (2012) Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice. J. Cardiovasc. Pharmacol. 59, 66-76.
68. Chamberlain, C. M., Ang, L. S., Boivin, W. A., Cooper, D. M., Williams, S. J., Zhao, H., Hendel, A., Folkesson, M., Swedenborg, J., Allard, M. F. et al. (2010) Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. Am. J. Pathol. 176, 1038-1049.
69. Bai, L., Beckers, L., Wijnands, E., Lutgens, S. P., Herias, M. V., Saftig, P., Daemen, M. J., Cleutjens, K., Lutgens, E., Biessen, E. A. and Heeneman, S. (2009) Cathepsin K gene disruption does not affect murine aneurysm formation. Atherosclerosis 209, 96-103.
70. Schulte, S., Sun, J., Libby, P., Macfarlane, L., Sun, C., Lopez-Ilasaca, M., Shi, G. P. and Sukhova, G. K. (2010) Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. Am. J. Pathol. 177, 456-463.
71. deBlois, D., Lombardi, D. M., Su, E. J., Clowes, A. W., Schwartz, S. M. and Giachelli, C. M. (1996) Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension 28, 1055-1063.
72. Bruemmer, D., Collins, A. R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M. C., Blaschke, F., Kintscher, U., Graf, K. et al. (2003) Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J. Clin. Invest. 112, 1318-1331.
73. -/- mice. J. Cardiovasc. Pharmacol. 53, 60-65.
74. 2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. Atherosclerosis 214, 58-64.
75. Watanabe, K., Fujioka, D., Saito, Y., Nakamura, T., Obata, J. E., Kawabata, K., Watanabe, Y., Mishina, H., Tamaru, S., Hanasaki, K. and Kugiyama, K. (2012) Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice. Am. J. Physiol. Heart Circ. Physiol. 302, H95-H104.
76. Tang, E. H., Shvartz, E., Shimizu, K., Rocha, V. Z., Zheng, C., Fukuda, D., Shi, G. P., Sukhova, G. and Libby, P. (2011) Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler., Thromb., Vasc. Biol. 31, 261-269.
77. Wang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Pure, E. and FitzGerald, G. A. (2008) Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117, 1302-1309.
78. Ahluwalia, N., Lin, A. Y., Tager, A. M., Pruitt, I. E., Anderson, T. J., Kristo, F., Shen, D., Cruz, A. R., Aikawa, M., Luster, A. D. and Gerszten, R. E. (2007) Inhibited aortic aneurysm formation in BLT1-deficient mice. J. Immunol. 179, 691-697.
79. Kristo, F., Hardy, G. J., Anderson, T. J., Sinha, S., Ahluwalia, N., Lin, A. Y., Passeri, J., Scherrer-Crosbie, M. and Gerszten, R. E. (2010) Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation. Atherosclerosis 210, 107-113.
80. Cao, R. Y., Adams, M. A., Habenicht, A. J. and Funk, C. D. (2007) Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. Prostaglandins Other Lipid Mediat. 84, 34-42.
81. Revermann, M., Mieth, A., Popescu, L., Paulke, A., Wurglics, M., Pellowska, M., Fischer, A., Steri, R., Maier, T., Schermuly, R. et al. (2011) A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine aortic aneurysm model. Br. J. Pharmacol. 163, 1721-1732.
82. Thomas, M., Gavrila, D., McCormick, M. L., Miller, Jr, F. J., Daugherty, A., Cassis, L. A., Dellsperger, K. C. and Weintraub, N. L. (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114, 404-413.
83. Haldar, S. M., Lu, Y., Jeyaraj, D., Kawanami, D., Cui, Y., Eapen, S. J., Hao, C., Li, Y., Doughman, Y. Q., Watanabe, M. et al. (2010) Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci. Transl. Med. 2, 26ra26.
84. Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A. J., Vinciguerra, M., Rosenthal, N., Sciacca, S., Pilato, M. et al. (2011) MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109, 1115-1119.
85. Maegdefessel, L., Azuma, J., Toh, R., Merk, D. R., Deng, A., Chin, J. T., Raaz, U., Schoelmerich, A. M., Raiesdana, A., Leeper, N. J. et al. (2012) Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J. Clin. Invest. 122, 497-506.
86. Dua, M. M. and Dalman, R. L. (2010) Hemodynamic influences on abdominal aortic aneurysm disease: application of biomechanics to aneurysm pathophysiology. Vasc. Pharmacol. 53, 11-21.
87. Majesky, M. W., Dong, X. R. and Hoglund, V. J. (2011) Parsing aortic aneurysms: more surprises. Circ. Res. 108, 528-530.
88. Zhu, L., Vranckx, R., Khau Van Kien, P., Lalande, A., Boisset, N., Mathieu, F., Wegman, M., Glancy, L., Gasc, J. M., Brunotte, F. et al. (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 38, 343-349.
89. Pannu, H., Tran-Fadulu, V., Papke, C. L., Scherer, S., Liu, Y., Presley, C., Guo, D., Estrera, A. L., Safi, H. J., Brasier, A. R. et al. (2007) MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum. Mol. Genet. 16, 3453-3462.
90. Guo, D. C., Pannu, H., Tran-Fadulu, V., Papke, C. L., Yu, R. K., Avidan, N., Bourgeois, S., Estrera, A. L., Safi, H. J., Sparks, E. et al. (2007) Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39, 1488-1493.
91. Huang, J., Davis, E. C., Chapman, S. L., Budatha, M., Marmorstein, L. Y., Word, R. A. and Yanagisawa, H. (2010) Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ. Res. 106, 583-592.
92. 1) receptor blockade. PLoS ONE 6, e23411.
93. Jones, J. A., Zavadzkas, J. A., Chang, E. I., Sheats, N., Koval, C., Stroud, R. E., Spinale, F. G. and Ikonomidis, J. S. (2010) Cellular phenotype transformation occurs during thoracic aortic aneurysm development. J. Thorac. Cardiovasc. Surg. 140, 653-659.
94. Tieu, B. C., Ju, X., Lee, C., Sun, H., Lejeune, W., Recinos, III, A., Brasier, A. R. and Tilton, R. G. (2010) Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling. J. Vasc. Res. 48, 261-272.
95. Nataatmadja, M., West, J. and West, M. (2006) Overexpression of transforming growth factor-β is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 114, I371-I377.
96. Brooke, B. S., Habashi, J. P., Judge, D. P., Patel, N., Loeys, B. and Dietz, III, H. C. (2008) Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N.Engl.J.Med.358, 2787-2795.
97. Matt, P., Schoenhoff, F., Habashi, J., Holm, T., Van Erp, C., Loch, D., Carlson, O. D., Griswold, B. F., Fu, Q., De Backer, J. et al. (2009) Circulating transforming growth factor-β in Marfan syndrome. Circulation 120, 526-532.
98. Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., Chen, Y., Modiri, A. N., Judge, D. P. and Dietz, H. C. (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361-365.
99. Moltzer, E., Essers, J., van Esch, J. H., Roos-Hesselink, J. W. and Danser, A. H. (2011) The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol. Ther. 131, 50-60.
100. Yang,H.H.,Kim,J.M.,Chum,E.,van Breemen,C. and Chung, A. W. (2010) Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. J. Thorac. Cardiovasc. Surg. 140, 305-312.e2.
101. 2 in vascular smooth muscle cells: molecular mechanisms. Circ. Res. 86, 1266-1272.
102. Jones, G. T., Thompson, A. R., van Bockxmeer, F. M., Hafez, H., Cooper, J. A., Golledge, J., Humphries, S. E., Norman, P. E. and van Rij, A. M. (2008) Angiotensin II type 1 receptor 1166C polymorphism Is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler., Thromb., Vasc. Biol. 28, 764-770.
103. Hackam, D. G., Thiruchelvam, D. and Redelmeier, D. A. (2006) Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 368, 659-665.
104. Thompson, A., Cooper, J. A., Fabricius, M., Humphries, S. E., Ashton, H. A. and Hafez, H. (2010) An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J. Vasc. Surg. 52, 55-61.
105. Sweeting, M. J., Thompson, S. G., Brown, L. C., Greenhalgh, R. M. and Powell, J. T. (2010) Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J. Vasc. Surg. 52, 1-4.
106. Lesauskaite, V., Sinkunaite-Marsalkiene, G., Tamosiunas, A. and Benetis, R. (2011) Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta. Eur. J. Cardiothorac. Surg. 40, 23-27.
107. Foffa, I., Murzi, M., Mariani, M., Mazzone, A. M., Glauber, M., Ait Ali, L. and Andreassi, M. G. (2012) Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves. J. Thorac. Cardiovasc. Surg., doi 10.1016/j.jtcvs.2011.12.038.
108. Lacro, R. V., Dietz, H. C., Wruck, L. M., Bradley, T. J., Colan, S. D., Devereux, R. B., Klein, G. L., Li, J. S., Minich, L. L., Paridon, S. M. et al. (2007) Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am. Heart J. 154, 624-631.
109. Cassis, L. A., Helton, M. J., Howatt, D. A., King, V. L. and Daugherty, A. (2005) Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br. J. Pharmacol. 144, 443-448.
110. Wu, G., Chen, T., Shahsafaei, A., Hu, W., Bronson, R. T., Shi, G. P., Halperin, J. A., Aktas, H. and Qin, X. (2010) Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice. Circulation 121, 1338-1346.
111. Xiao, J., Angsana, J., Wen, J., Smith, S. V., Park, P. W., Ford, M. L., Haller, C. A. and Chaikof, E. L. (2012) Syndecan-1 displays a protective role in aortic aneurysm formation by modulating T cell-mediated responses. Arterioscler., Thromb., Vasc. Biol. 32, 386-396.
112. McAllister-Lucas, L. M., Jin, X., Gu, S., Siu, K., McDonnell, S., Ruland, J., Delekta, P. C., Van Beek, M. and Lucas, P. C. (2010) The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J. Biol. Chem. 285, 25880-25884.
113. Fornasa, G., Clement, M., Groyer, E., Gaston, A. T., Khallou-Laschet, J., Morvan, M., Guedj, K., Kaveri, S. V., Tedgui, A., Michel, J. B. et al. (2012) A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc. Res. 94, 30-37.
114. Choke, E., Cockerill, G. W., Dawson, J., Howe, F., Wilson, W. R., Loftus, I. M. and Thompson, M. M. (2010) Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. J. Vasc. Surg. 52, 159-166.e1.
115. Deguchi, J. O., Huang, H., Libby, P., Aikawa, E., Whittaker, P., Sylvan, J., Lee, R. T. and Aikawa, M. (2009) Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab. Invest. 89, 315-326.
116. Wang, S., Subramanian, V., Lu, H., Howatt, D. A., Moorleghen, J. J., Charnigo, R., Cassis, L. A. and Daugherty, A. (2012) Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms. Atherosclerosis 220, 375-380.
117. King, V. L., Trivedi, D., Gitlin, J. M. and Loftin, C. D. (2006) Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler. Thromb., Vasc. Biol. 26, 1137-1143.
118. Gitlin, J. M., Trivedi, D. B., Langenbach, R. and Loftin, C. D. (2007) Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc. Res. 73, 227-236.
119. Maiellaro-Rafferty, K., Weiss, D., Joseph, G., Wan, W., Gleason, R. L. and Taylor, W. R. (2011) Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am. J. Physiol. Heart Circ. Physiol. 301, H355-H362.
120. Zhang, L. N., Vincelette, J., Cheng, Y., Mehra, U., Chen, D., Anandan, S. K., Gless, R., Webb, H. K. and Wang, Y. X. (2009) Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler. Thromb., Vasc. Biol. 29, 1265-1270.
121. Satoh, K., Nigro, P., Matoba, T., O'Dell, M. R., Cui, Z., Shi, X., Mohan, A., Yan, C., Abe, J., Illig, K. A. and Berk, B. C. (2009) Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat. Med. 15, 649-656.
122. Jiang, F., Jones, G. T. and Dusting, G. J. (2007) Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice. Br. J. Pharmacol. 152, 880-890.
123. Uchida, H. A., Sugiyama, H., Takiue, K., Kikumoto, Y., Inoue, T. and Makino, H. (2011) Development of angiotensin II-induced abdominal aortic aneurysms is independent of catalase in mice. J. Cardiovasc. Pharmacol. 58, 633-638.
124. Esteban, V., Mendez-Barbero, N., Jimenez-Borreguero, L. J., Roque, M., Novensa, L., Garcia-Redondo, A. B., Salaices, M., Vila, L., Arbones, M. L., Campanero, M. R. and Redondo, J. M. (2011) Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J. Exp. Med. 208, 2125-2139.
125. Jones, A., Deb, R., Torsney, E., Howe, F., Dunkley, M., Gnaneswaran, Y., Gaze, D., Nasr, H., Loftus, I. M., Thompson, M. M. and Cockerill, G. W. (2009) Rosiglitazone. reduces the development and rupture of experimental aortic aneurysms. Circulation 119, 3125-3132.
126. Golledge, J., Cullen, B., Rush, C., Moran, C. S., Secomb, E., Wood, F., Daugherty, A., Campbell, J. H. and Norman, P. E. (2010) Peroxisome. proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis 210, 51-56.
127. Vinh, A., Gaspari, T. A., Liu, H. B., Dousha, L. F., Widdop, R. E. and Dear, A. E. (2008) A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J. Vasc. Res. 45, 143-152.
128. Subramanian, V., Golledge, J., Ijaz, T., Bruemmer, D. and Daugherty, A. (2010) Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPARγ. Circ. Res. 107, 953-958.
129. Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A.J.G., Vinciguerra, M., Rosenthal, N., Sergio, S., Pilato, M. et al. (2011) MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109, 1115-1119.
130. Maegdefessel, L., Azuma, J., Toh, R., Deng, A., Merk, D. R., Raiesdana, A., Leeper, N. J., Raaz, U., Schoelmerich, A. M., McConnell, M. V., Dalman, R. L., Spin, J. M. and Tsao, P. S. (2012) MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine- augmented expansion. Sci. Transl. Med. 4, 122ra22.